Aqueous polyisocyanate crosslinking agents modified with hydroxycarboxylic acids and pyrazole-based blocking agents
CA 2265070 A1 · Owner: Bayer Aktiengesellschaft · Inventors: Petzoldt, Joachim; Konig, Eberhard; Muller, Heino
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to aqueous or water dilutable blocked polyisocyanates containing, a) a polyisocyanate component and based on the equivalents of, isocyanate groups b) 60 to 85 equivalent % of a pyrazole blocking agent c) 15 to 40 equivalent % of a monohydroxycarboxylic acid to impart hydrophilic properties and, d) 0 to 15 equivalent % of a difunctional chain extender containing OH and/or NH2 groups, wherein the amounts of a) to d) are selected so that the equivalent ratio of NCO groups of component a) to isocyanate-reactive groups of components b), c) and d) is 1:0.8 to 1:1.2. The present invention also relates to a process for preparing these polyisocyanate crosslinking agents …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 8, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.